These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2676940)
1. Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibiotics. Nélet F; Gutmann L; Kitzis MD; Acar JF J Antimicrob Chemother; 1989 Aug; 24(2):173-81. PubMed ID: 2676940 [TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria. Raimondi A; Cocuzza CE J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698 [TBL] [Abstract][Full Text] [Related]
3. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae]. Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532 [TBL] [Abstract][Full Text] [Related]
4. Tigemonam, an oral monobactam. Chin NX; Neu HC Antimicrob Agents Chemother; 1988 Jan; 32(1):84-91. PubMed ID: 3279906 [TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-production. Brown J; Yang YJ; Livermore DM J Antimicrob Chemother; 1989 Feb; 23(2):201-7. PubMed ID: 2785102 [TBL] [Abstract][Full Text] [Related]
6. The in vitro activity of tigemonam: a comparison with other antimicrobial agents. Andrews JM; Wise R J Chemother; 1989 May; 1 Suppl 2():5-12. PubMed ID: 2509645 [TBL] [Abstract][Full Text] [Related]
7. Comparative in-vitro activity of tigemonam, a new monobactam. Rylander M; Gezelius L; Norrby SR J Antimicrob Chemother; 1988 Sep; 22(3):307-13. PubMed ID: 3182428 [TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins. Jarlier V; Nicolas MH; Philippon A; Giroir AM; Grosset J J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939 [TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of tigemonam, a novel oral monobactam. Tanaka SK; Summerill RA; Minassian BF; Bush K; Visnic DA; Bonner DP; Sykes RB Antimicrob Agents Chemother; 1987 Feb; 31(2):219-25. PubMed ID: 3105448 [TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity in vitro of tigemonam, a new oral monobactam. Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A J Chemother; 1989 May; 1 Suppl 2():41-4. PubMed ID: 2809702 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of tigemonam against urinary tract pathogens. Garcia-Rodriguez JA; Garcia-Sanchez JE J Chemother; 1989 May; 1 Suppl 2():28-31. PubMed ID: 2809699 [TBL] [Abstract][Full Text] [Related]
12. Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228. Reck F; Bermingham A; Blais J; Capka V; Cariaga T; Casarez A; Colvin R; Dean CR; Fekete A; Gong W; Growcott E; Guo H; Jones AK; Li C; Li F; Lin X; Lindvall M; Lopez S; McKenney D; Metzger L; Moser HE; Prathapam R; Rasper D; Rudewicz P; Sethuraman V; Shen X; Shaul J; Simmons RL; Tashiro K; Tang D; Tjandra M; Turner N; Uehara T; Vitt C; Whitebread S; Yifru A; Zang X; Zhu Q Bioorg Med Chem Lett; 2018 Feb; 28(4):748-755. PubMed ID: 29336873 [TBL] [Abstract][Full Text] [Related]
13. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam. Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae. Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G J Chemother; 1989 May; 1 Suppl 2():32-5. PubMed ID: 2809700 [TBL] [Abstract][Full Text] [Related]
15. Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing Dean CR; Barkan DT; Bermingham A; Blais J; Casey F; Casarez A; Colvin R; Fuller J; Jones AK; Li C; Lopez S; Metzger LE; Mostafavi M; Prathapam R; Rasper D; Reck F; Ruzin A; Shaul J; Shen X; Simmons RL; Skewes-Cox P; Takeoka KT; Tamrakar P; Uehara T; Wei JR Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061293 [TBL] [Abstract][Full Text] [Related]
16. Antibacterial Activity of Tigemonam Dicholate (SQ 30836) and Interaction With Beta-Lactamases of Gram-Negative Bacteria. Raimondi A; Cocuzza CE J Chemother; 1989 May; 1(sup2):13-21. PubMed ID: 27416144 [TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial activity of tigemonam, a new orally administered monobactam. Fuchs PC; Jones RN; Barry AL Antimicrob Agents Chemother; 1988 Mar; 32(3):346-9. PubMed ID: 3259122 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related]
20. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters. Mushtaq S; Woodford N; Hope R; Adkin R; Livermore DM J Antimicrob Chemother; 2013 Jul; 68(7):1601-8. PubMed ID: 23449829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]